Table: begin end state 1 24 cytoplasmic 25 43 transmembrane 44 54 non-cytoplasmic 55 81 transmembrane 82 90 cytoplasmic 91 114 transmembrane 115 115 non-cytoplasmic 116 145 transmembrane 146 161 cytoplasmic 162 181 transmembrane 182 189 non-cytoplasmic 190 210 transmembrane 211 241 cytoplasmic 242 260 transmembrane 261 278 non-cytoplasmic 279 296 transmembrane 297 307 cytoplasmic 308 328 transmembrane 329 336 non-cytoplasmic 337 359 transmembrane 360 368 cytoplasmic 369 392 transmembrane 393 403 non-cytoplasmic 404 422 transmembrane 423 432 cytoplasmic
Input: >AO353_25075 MMKTTTQDTRSKGSKLGAILRVTSGNFLEQFDFFLFGFYATYISQTFFPTTSEFASLMMT FAVFGSGFLMRPLGAIVLGAYIDKVGRRKGLIVTLSIMAAGTVLIALVPGYASIGIAAPI LVLLGRLLQGFSAGAEMGGVSVYLAEIATPGRRGFYTSWQSASQQVAIILAAALGYTINA SMEAADVAAWGWRIPFFIGCLIIPFIFIIRRSLQETDAFKARSHHPSASEVFRSMRDNWR TVLAGGLLASMTTTTFYLITVYTPTFGRSVLNLSTSDSLVVTLFVGLSNFIWLPIGGTIS DRIGRRPLLLAVTLLCIFTAYPAMHWLAAAASFERLLAVLLYFSFFFGIYNGAMVAALTE VMPQNVRVVGFSLAFSLATAVFGGFTPAVSTILVQATGDKASPAYWLMFAALCGFTATTI LYRRQKAVPVNV
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server